Invitae Releases Data Use Transparency Report, Demonstrating Impact of Patient Data on Genetic Research
– Invited to report on the secondary use of patient data, demonstrating the true impact of anonymized patient data on the advancement of precision medicine – – Company Achieves Over 1 Million ClinVar Submissions to Advance Science and Patient Care – SAN FRANCISCO, December 7, 2022 /PRNewswire/ — Invite (NYSE: NVTA), a leading medical genetics …